NEXGEL, Inc. (NXGLW) stock
NXGLWNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as NXGL
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 17, 2026Score 6/3072% below fair value
$0.01+0.00 (0.00%)
Close on Oct 30, 2026Market cap $34.21MP/E –Yield –
Nexgel operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Nexgel's operating income for the twelve months ending Jun 30, 2026 was -$5.40M. For fiscal 2025 it was -$3.35M. The highest annual figure on record is -$1.89M in fiscal 2018.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$3.35M | – |
| FY2024 | Dec 31, 2024 | -$3.55M | – |
| FY2023 | Dec 31, 2023 | -$3.48M | – |
| FY2022 | Dec 31, 2022 | -$3.35M | – |
| FY2021 | Dec 31, 2021 | -$2.57M | – |
| FY2020 | Dec 31, 2020 | -$2.26M | – |
| FY2019 | Dec 31, 2019 | -$1.92M | – |
| FY2018 | Dec 31, 2018 | -$1.89M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$2.51M | – |
| Q1 FY2026 | Mar 31, 2026 | -$958.00K | – |
| Q4 FY2025 | Dec 31, 2025 | -$1.21M | – |
| Q3 FY2025 | Sep 30, 2025 | -$725.00K | – |
| Q2 FY2025 | Jun 30, 2025 | -$636.00K | – |
| Q1 FY2025 | Mar 31, 2025 | -$777.00K | – |
| Q4 FY2024 | Dec 31, 2024 | -$841.00K | – |
| Q3 FY2024 | Sep 30, 2024 | -$788.00K | – |
| Q2 FY2024 | Jun 30, 2024 | -$1.05M | – |
| Q1 FY2024 | Mar 31, 2024 | -$871.00K | – |
| Q4 FY2023 | Dec 31, 2023 | -$1.22M | – |
| Q3 FY2023 | Sep 30, 2023 | -$612.00K | – |
| Q2 FY2023 | Jun 30, 2023 | -$762.00K | – |
| Q1 FY2023 | Mar 31, 2023 | -$883.00K | – |
| Q4 FY2022 | Dec 31, 2022 | -$781.00K | – |
| Q3 FY2022 | Sep 30, 2022 | -$1.04M | – |
| Q2 FY2022 | Jun 30, 2022 | -$718.00K | – |
| Q1 FY2022 | Mar 31, 2022 | -$812.00K | – |
| Q4 FY2021 | Dec 31, 2021 | -$887.00K | – |
| Q3 FY2021 | Sep 30, 2021 | -$610.00K | – |
| Q2 FY2021 | Jun 30, 2021 | -$553.00K | – |
| Q1 FY2021 | Mar 31, 2021 | -$520.00K | – |
| Q4 FY2020 | Dec 31, 2020 | -$676.00K | – |
| Q3 FY2020 | Sep 30, 2020 | -$535.00K | -823.0% |
| Q2 FY2020 | Jun 30, 2020 | -$540.00K | – |
| Q1 FY2020 | Mar 31, 2020 | -$509.00K | – |
| Q4 FY2019 | Dec 31, 2019 | -$313.00K | – |
| Q3 FY2019 | Sep 30, 2019 | $74.00K | – |
| Q2 FY2019 | Jun 30, 2019 | -$1.07M | – |
| Q1 FY2019 | Mar 31, 2019 | -$612.00K | – |
| Q2 FY2018 | Jun 30, 2018 | -$287.00K | – |